878809-67-7

Basic information

• Product Name: 4-(3-chloro-4-fluoro-phenyl)-6-[4-(3-methyl-5-nitro-pyridin-2-yl)-piperazin-1-yl]-2-(2-methyl-pyrrolidin-1-yl)-pyrimidine
• Synonyms: 4-(3-chloro-4-fluoro-phenyl)-6-[4-(3-methyl-5-nitro-pyridin-2-yl)-piperazin-1-yl]-2-(2-methyl-pyrrolidin-1-yl)-pyrimidine
• CAS NO: 878809-67-7
• Molecular Weight: 511.986
• Mol File: 878809-67-7.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 4-(3-chloro-4-fluoro-phenyl)-6-[4-(3-methyl-5-nitro-pyridin-2-yl)-piperazin-1-yl]-2-(2-methyl-pyrrolidin-1-yl)-pyrimidine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(3-chloro-4-fluoro-phenyl)-6-[4-(3-methyl-5-nitro-pyridin-2-yl)-piperazin-1-yl]-2-(2-methyl-pyrrolidin-1-yl)-pyrimidine(878809-67-7)
• EPA Substance Registry System: 4-(3-chloro-4-fluoro-phenyl)-6-[4-(3-methyl-5-nitro-pyridin-2-yl)-piperazin-1-yl]-2-(2-methyl-pyrrolidin-1-yl)-pyrimidine(878809-67-7)

Safety Data

• Hazardous Substances Data: 878809-67-7(Hazardous Substances Data)

Upstream product

• 765-38-8 2-methyl-1-pyrrolidine 
• 144432-85-9 3-chloro-4-fluorophenylboronic acid 
• 833472-83-6 4,6-dichloro-2-(2-methyl-pyrrolidin-1-yl)-pyrimidine 
• 878809-66-6 1-(3-methyl-5-nitro-pyridin-2-yl)-piperazine 
• 22280-56-4 2-chloro-3-methyl-5-nitropyridine 
• 878810-06-1 4-(3-chloro-4-fluoro-phenyl)-2-(2-methyl-pyrrolidin-1-yl)-6-piperazin-1-yl-pyrimidine 

Downstream Products

• 878809-68-8 6-{4-[6-(3-chloro-4-fluoro-phenyl)-2-(2-methyl-pyrrolidin-1-yl)-pyrimidin-4-yl]-piperazin-1-yl}-5-methyl-pyridin-3-ylamine 

Relevant articles and documents

SUBSTITUTED BIARYL PIPERAZINYL-PYRIDINE ANALOGUES

Substituted biaryl piperazinyl-pyridine analogues are provided, of the Formula (I): wherein variables are as described herein. Such compounds are ligands that may be used to modulate specific receptor activity in vivo or in vitro,and are particularly useful in the treatment of conditions associated with pathological receptor activation in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for using such compounds to treat such disorders are provided, as are methods for using such ligands for receptor localization studies.